Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)
Phase 2
Completed
- Conditions
- Atopic DermatitisEczema
- First Posted Date
- 2004-01-23
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Nucryst Pharmaceuticals
- Target Recruit Count
- 180
- Registration Number
- NCT00076375
- Locations
- 🇺🇸
National Allergy, Asthma & Urticaria Centers of Charleston, P.A., Charleston, South Carolina, United States
🇺🇸nTouch Research, Washington, District of Columbia, United States
🇺🇸University Hospitals of Cleveland, Cleveland, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath